Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ProMetic Life Sciences meets with FDA on regulatory pathway of PBI-1402

Dec. 15, 2009

Phase III program of TAK-085 in hypertriglyceridemia initiated in Japan

Dec. 15, 2009

FDA approves use of Diamyd vaccine in young children in TrialNet GAD diabetes study

Dec. 15, 2009

Protalix Biotherapeutics submits NDA to FDA for taliglucerase alfa for Gaucher's disease

Dec. 11, 2009

Sangart initiates phase IIa study of oxygen therapeutic agent MP-4OX

Dec. 11, 2009

Banyu presents MCH-R1 antagonists for treatment of obesity and diabetes

Dec. 11, 2009

Novel PHD inhibitors presented by Janssen for anemia therapy

Dec. 11, 2009

Novel glucokinase activators discovered at Takeda

Dec. 11, 2009

Neurocrine reports results from phase II trial of elagolix in endometriosis

Dec. 11, 2009

Vissane approved in Europe for endometriosis

Dec. 10, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...